The potential of fiber optic chemical sensors (FOGS) for medical applications is an accepted fact. Indeed, many companies are arduously pursuing the pH, pCO2, and p02 sensors. These, however, only represent the beginning of what, eventually, could be the next generation approach to diagnostics and monitoring. The key to a good FOGS system is to: (i) make, or adapt, accepted laboratory chemistry so that it works, without loss of sensitivity or specificity, on a fiber optic; (ii) assure that sensor neither affects, or is affected by, the biological meltum into which it is placed; (iii) have optimized, dedicated instrumentation to illuminate the sensor, and to handle and process its output signal; and (iv) perform a necessary diagnostic, monitoring or clinical function better, faster, more accurately or less expensively than existing approacbes. Theoretically, there are no limits to the reactions that can be selected to identify and quantify a particular chemical or physical happening using a species specific FOGS. In practice, however, the choices are restricted because: (i) many of the existing tests use sample prepreparation, such as concentration and purification, which is not possible for many FOGS usages; (ii) the chemistry on the fiber must meet FDA criteria; (iii) the chemistry is not stable enough for long term storage and (iv) measurements which are marginal in the laboratory, will not work on a fiber. In the present research the potential of using enzymes as the sensing material is being evaluated. To date emphasis has been placed on the immobilization of the enzyme on the fiber optic without loss of activity or specificity. The selected enzyme for this effort is 3α-hydroxysteroid dehydrogenase. It was selected with the eventual goal of analyzing bile acid concentrations.